Compositions comprising recombinant Bacillus cells and an insecticide

US11044916B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11044916-B2
Application numberUS-201515511864-A
CountryUS
Kind codeB2
Filing dateSep 17, 2015
Priority dateSep 17, 2014
Publication dateJun 29, 2021
Grant dateJun 29, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: (a) recombinant exosporium-producing Bacillus cells of a Bacillus cereus family member that express a fusion protein comprising: (i) an aminocyclopropane-1-carboxylic acid deaminase; and (ii) a targeting sequence, or an exosporium protein, wherein the targeting sequence or the exosporium protein comprises: an amino acid sequence having at least 43% sequence identity with amino acids 20-35 of SEQ ID NO: 1, wherein the sequence identity with amino acids 25-35 of SEQ ID NO: 1 is at least 54%; a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1; a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1; a targeting sequence comprising amino acids 22-31 of SEQ ID NO: 1; a targeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; a targeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; a targeting sequence comprising SEQ ID NO: 1; or an exosporium protein comprising an amino acid sequence having at least 85% sequence identity with SEQ ID NO: 2 and (b) at least one insecticide selected from the group consisting of abamectin, carbofuran, cyazypyr, cycloaprid, spinosad, sulfoxaflor, and tefluthrin, in a synergistically effective amount. 2. The composition of claim 1 , wherein the recombinant Bacillus cells are from Bacillus thuringiensis BT013A. 3. The composition according to claim 1 , wherein the at least one insecticide is spinosad. 4. The composition according to claim 1 , wherein the at least one insecticide is abamectin. 5. The composition according to claim 1 , wherein the at least one insecticide is carbofuran. 6. A seed treated with the composition according to claim 1 . 7. A method of treating a plant, a plant part, or the locus surrounding the plant to enhance plant growth and/or promote plant health comprising the step of simultaneously or sequentially applying: a) recombinant exosporium-producing Bacillus cells of a Bacillus cereus family member that express a fusion protein comprising: (i) an aminocyclopropane-1-carboxylic acid deaminase; and (ii) a targeting sequence, or an exosporium protein, wherein the targeting sequence or the exosporium protein comprises: an amino acid sequence having at least 43% sequence identity with amino acids 20-35 of SEQ ID NO: 1, wherein the sequence identity with amino acids 25-35 of SEQ ID NO: 1 is at least 54%; a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1; a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1; a targeting sequence comprising amino acids 22-31 of SEQ ID NO: 1; a targeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; a targeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; a targeting sequence comprising SEQ ID NO: 1; or an exosporium protein comprising an amino acid sequence having at least 85% sequence identity with SEQ ID NO: 2 and (b) at least one insecticide selected from the group consisting of abamectin, carbofuran, cyazypyr, cycloaprid, spinosad, sulfoxaflor, and tefluthrin, in a synergistically effective amount.

Assignees

Inventors

Classifications

  • A61K39/07Primary

    Bacillus · CPC title

  • Phospholipase A2 (3.1.1.4) · CPC title

  • C12Y301/01Primary

    Carboxylic ester hydrolases (3.1.1) · CPC title

  • Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase · CPC title

  • Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11044916B2 cover?
The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistic…
Who is the assignee on this patent?
Bayer Cropscience Lp, Spogen Biotech Inc
What technology area does this patent fall under?
Primary CPC classification A61K39/07. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).